{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:50:45Z","timestamp":1784011845918,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50 HD093540"],"award-info":[{"award-number":["P50 HD093540"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201300017C"],"award-info":[{"award-number":["HHSN275201300017C"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1 U01 HD076542"],"award-info":[{"award-number":["1 U01 HD076542"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.contraception.2024.110809","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T10:28:22Z","timestamp":1735986502000},"page":"110809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review"],"prefix":"10.1016","volume":"145","author":[{"given":"Rui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra J.","family":"Wolgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-9460","authenticated-orcid":false,"given":"Gunda I.","family":"Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.contraception.2024.110809_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0021-9258(18)88530-1","article-title":"The relation of growth to the chemical constituents of the diet","volume":"15","author":"Osborne","year":"1913","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.contraception.2024.110809_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.42.6.753","article-title":"Tissue changes following deprivation of fat-soluble a vitamin","volume":"42","author":"Wolbach","year":"1925","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.contraception.2024.110809_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg2340","article-title":"Retinoic acid in development: towards an integrated view","volume":"9","author":"Niederreither","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"15","key":"10.1016\/j.contraception.2024.110809_bib4","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1073\/pnas.90.15.7225","article-title":"High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice","volume":"90","author":"Lufkin","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.contraception.2024.110809_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/dvdy.20083","article-title":"Retinoic acid receptor alpha is required for synchronization of spermatogenic cycles and its absence results in progressive breakdown of the spermatogenic process","volume":"230","author":"Chung","year":"2004","journal-title":"Dev Dyn"},{"issue":"4","key":"10.1016\/j.contraception.2024.110809_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1432-0436.2005.00018.x","article-title":"Male sterility in mice lacking retinoic acid receptor alpha involves specific abnormalities in spermiogenesis","volume":"73","author":"Chung","year":"2005","journal-title":"Differentiation"},{"issue":"2-4","key":"10.1016\/j.contraception.2024.110809_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000078189","article-title":"Role of retinoid signaling in the regulation of spermatogenesis","volume":"105","author":"Chung","year":"2004","journal-title":"Cytogenet Genome Res"},{"issue":"12","key":"10.1016\/j.contraception.2024.110809_bib8","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1242\/dev.020040","article-title":"Expression of retinoic acid receptor alpha in the germline is essential for proper cellular association and spermiogenesis during spermatogenesis","volume":"136","author":"Chung","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.contraception.2024.110809_bib9","first-page":"11","article-title":"Retinoid signaling during spermatogenesis as revealed by genetic and metabolic manipulations of retinoic acid receptor alpha","volume":"63","author":"Wolgemuth","year":"2007","journal-title":"Soc Reprod Fertil Suppl"},{"issue":"2","key":"10.1016\/j.contraception.2024.110809_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/toxsci\/59.2.297","article-title":"BMS-189453, a novel retinoid receptor antagonist, is a potent testicular toxin","volume":"59","author":"Schulze","year":"2001","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.contraception.2024.110809_bib11","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1210\/en.2010-0941","article-title":"Oral administration of a retinoic acid receptor antagonist reversibly inhibits spermatogenesis in mice","volume":"152","author":"Chung","year":"2011","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.contraception.2024.110809_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1210\/en.2015-1675","article-title":"Prolonged oral administration of a pan-retinoic acid receptor antagonist inhibits spermatogenesis in mice with a rapid recovery and changes in the expression of influx and efflux transporters","volume":"157","author":"Chung","year":"2016","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.contraception.2024.110809_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ml300365k","article-title":"Pharmacological activity of retinoic acid receptor alpha-selective antagonists in vitro and in vivo","volume":"4","author":"Chung","year":"2013","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"10.1016\/j.contraception.2024.110809_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nsmb.1855","article-title":"A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor","volume":"17","author":"le Maire","year":"2010","journal-title":"Nat Struct Mol Biol"},{"issue":"6868","key":"10.1016\/j.contraception.2024.110809_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/415187a","article-title":"Co-regulator recruitment and the mechanism of retinoic acid receptor synergy","volume":"415","author":"Germain","year":"2002","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.contraception.2024.110809_bib16","doi-asserted-by":"crossref","first-page":"19401","DOI":"10.1074\/jbc.M002472200","article-title":"Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands.\u00a0Influence of DNA-heterodimer interactions","volume":"275","author":"Klein","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.contraception.2024.110809_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0165-6147(00)01548-0","article-title":"Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications","volume":"21","author":"Bourguet","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"10.1016\/j.contraception.2024.110809_bib18","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1021\/jm00016a020","article-title":"A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives","volume":"38","author":"Yoshimura","year":"1995","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.contraception.2024.110809_bib19","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.bmcl.2016.05.056","article-title":"Identification of potent and selective retinoic acid receptor gamma (RARgamma) antagonists for the treatment of osteoarthritis pain using structure based drug design","volume":"26","author":"Hughes","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"16","key":"10.1016\/j.contraception.2024.110809_bib20","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/jm9703911","article-title":"Identification of highly potent retinoic acid receptor alpha-selective antagonists","volume":"40","author":"Teng","year":"1997","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.contraception.2024.110809_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0960-894X(01)00177-9","article-title":"Syntheses and evaluation of quinoline derivatives as novel retinoic acid receptor alpha antagonists","volume":"11","author":"Kikuchi","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.contraception.2024.110809_bib22","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1074\/jbc.273.6.3490","article-title":"Serine 232 and methionine 272 define the ligand binding pocket in retinoic acid receptor subtypes","volume":"273","author":"Ostrowski","year":"1998","journal-title":"J Biol Chem"},{"issue":"6530","key":"10.1016\/j.contraception.2024.110809_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.contraception.2024.110809_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1097-2765(00)80424-4","article-title":"Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains","volume":"5","author":"Bourguet","year":"2000","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/j.contraception.2024.110809_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.embor.7400235","article-title":"Rational design of RAR-selective ligands revealed by RARbeta crystal stucture","volume":"5","author":"Germain","year":"2004","journal-title":"EMBO Rep"},{"issue":"7","key":"10.1016\/j.contraception.2024.110809_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300031","article-title":"Investigation of selective retinoic acid receptor alpha antagonist ER-50891 and related analogs for male contraception","volume":"356","author":"Kyzer","year":"2023","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.contraception.2024.110809_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115821","article-title":"Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception","volume":"261","author":"Al Noman","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.contraception.2024.110809_bib28","article-title":"Targeting the retinoid signaling pathway with YCT-529 for effective, reversible oral contraception in mice and primatestargeting the retinoid signaling pathway with YCT-529 for effective, reversible oral contraception in mice and primates","author":"Mannowetz","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.contraception.2024.110809_bib29","doi-asserted-by":"crossref","unstructured":"Russell LD, Ettlin RA, Hikim APS, Clegg ED. Histological and histopathological evaluation of the testis. Wiley Online Library; 1993.","DOI":"10.1111\/j.1365-2605.1993.tb01156.x"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424005237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424005237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T18:57:57Z","timestamp":1744916277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424005237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S0010782424005237"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110809","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110809"}}